ACE2 and COVID-19: Both SARS-CoV-2 virus and COVID-19 vaccine elicit an antibody response against the spike (S) protein, which is used by the coronavirus to bind to the angiotensin-converting-enzyme 2 (ACE2) receptor on target cells.